Market News
Zambia Cholera Vaccines Market- Recent Developments
- On January 20, 2024, Africa Centres for Disease Control and Prevention (CDC), is a public health agency of the African Union to support the public health initiatives of member states and strengthen the capacity of their health institutions to deal with disease threats, sensitised Heads of State and Government from the Southern Africa Development Community (SADC) regarding the increase of cholera-related cases and deaths in the region. Heads of State and Government then decided to organize an extraordinary summit hosted by the SADC Secretariat and led by President Lourenco from Angola as the Chair of SADC. This meeting was held virtually on February02, 2024 to receive and consider a report on the status of the cholera outbreak in the SADC region. They expressed concern on the progress made in curbing the situation and the challenges that continue to hamper the effective fight against the recurrent outbreaks.
- In August 2023, GC Biopharma, a global pharmaceutical company, signed a memorandum of understanding (MOU) with Eubiologics, a global biotechnology company to jointly manufacture oral cholera vaccine, Euvichol. The parties will jointly manufacture Euvichol from the first half of 2024 for supply to the United Nations International Children's Emergency Fund (UNICEF). UNICEF had sought further supply of vaccines apart from those of a plastic-tubed Euvichol-Plus to address the recent spread of cholera infection in various areas such as Africa.
U.S.: 
U.K. : 
India : 
